Regulus Therapeutics Inc (NASDAQ:RGLS)
| 0.21 Delayed Data As of Jan 26 |  +0.0033 / +1.60%Today’s Change | 0.19 Today|||52-Week Range 2.32 | -33.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 20.8M | 1.2M | 72.0K | 72.0K | |
| Depreciation And Amortization | 1.6M | 2.3M | 2.5M | 2.3M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 73.9M | 80.4M | 67.7M | 43.8M | ||
| Research And Development | 56.4M | 64.3M | 53.2M | 33.1M | ||
| Total Operating Expenses | 75.5M | 82.7M | 70.2M | 46.0M | ||
| Non-Operating Expenses | Operating Income | -54.8M | -81.5M | -70.1M | -46.0M | |
| Extraordinary Charge | -1.8M | 0.00 | 0.00 | -800.0K | ||
| Interest Expense On Debt | 52.0K | 1.2M | 2.7M | 2.3M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -55.8M | -81.8M | -72.1M | -48.6M | |
| Income Taxes | -18.0K | -4.0K | -197.0K | -62.0K | ||
| Net Income | -55.7M | -81.8M | -71.9M | -48.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 4.3M | 4.4M | 6.3M | 8.7M | |
| Shares To Calculate EPS Diluted | 4.3M | 4.4M | 6.3M | 8.7M | ||
| Earnings Per Share | EPS | -$12.96 | -$18.60 | -$11.52 | -$5.59 | |
| EPS Diluted | -$12.96 | -$18.60 | -$11.52 | -$5.59 | ||
